|
|
Volumn 3, Issue 6, 2011, Pages
|
|
Beyond amyloid: A diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementias
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID;
DAVUNETIDE;
FLORBETAPIR F 18;
HEAT SHOCK PROTEIN 70;
HEAT SHOCK PROTEIN 90;
HISTONE DEACETYLASE 2;
KLOTHO PROTEIN;
MW 151;
NEUROPROTECTIVE AGENT;
PY 101;
TETRAMETHYLPYRAZINE;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
AUTOPHAGY;
AUTOPSY;
BLOOD BRAIN BARRIER;
CALCIUM HOMEOSTASIS;
CLINICAL FEATURE;
COGNITIVE DEFECT;
CONFERENCE PAPER;
CYTOKINE PRODUCTION;
DEGENERATIVE DISEASE;
FRONTOTEMPORAL DEMENTIA;
HIGH THROUGHPUT SCREENING;
HUMAN;
LYSOSOME;
NERVE CELL PLASTICITY;
NEUROPROTECTION;
NONHUMAN;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
PROTEIN FOLDING;
RISK FACTOR;
|
|
EID: 84855590508
PISSN: None
EISSN: 17589193
Source Type: Journal
DOI: 10.1186/alzrt99 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (0)
|
